1 Followers on Owler
Cambryn develops and distributes biologic products for the management and treatment of clotting factor deficiencies... Read more
OverviewCompetitorsNews & Insights
Cambryn develops and distributes biologic products for the management and treatment of clotting factor deficiencies... Read more
Cambryn Biologics Co-Founder & CEO: Mark P Famiglio

Co-Founder & CEO

Mark P Famiglio

CEO Approval Rating

80/100

2011

Private

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
100-250
Agree?

News

Jul 19, 2016
Business Wire
Press Release: Cambryn Biologics : Global Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) Pipeline Review 2016 - Research and Markets

Cambryn Biologics Competitors

1Taibang Biologic Group
2BeiGene
3Sino Biological
4Brii Bio
5Sarepta
6Grifols
7Bio Products Laboratory
8Techpool
9Global Switch
10Entegrion
Unlock 11 + competitors

Trending Companies